Dapiglutide
Based on 1 publication(s) in Google Scholar
Dapiglutide (ZP7570) is a long-acting glucagon-like peptide-1 receptor 1R (GLP-1R)/Glucagon-like peptide-2 receptor (GLP-2R) dual agonist. Dapiglutide alleviates intestinal dysfunction in a mouse short bowel model and has anti-obesity effects.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 98.52%
- CAS No.: 2296814-85-0
- Formule: C192H302N46O57
- Masse moléculaire:4166.79
-
Stockage:
Sealed storage, away from moisture and light, under nitrogen.
Powder -80°C, 2 years , -20°C, 1 year* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen)
Publications Citing Use of MedChemExpress (MCE) Dapiglutide
More
Activité biologique
Description
In Vitro
Dapiglutide has an EC50 of 190 pM for GLP-1R and an EC50 of 210 pM for GLP-2R in HEK293 cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Dapiglutide (100 nmol/kg, once daily for four weeks) can reduce body weight in obese mice[3].
Pharmacokinetic Analysis in MC38 Syngeneic Model[2]
| Route | Dose (nmol/kg) | Animal | T1/2 (h) | Tmax (h) | F (%) |
| s.c. | 10 | Mice | 3.6 | 4.5 | 71 |
| s.c. | 10 | Rats | 7.7 | 9.0 | 58 |